Daniel Carpenter

Comprehensive NeuroScience (CNS) is a strategic clinical research partner providing a full range of services in various therapeutic areas with an outstanding record for consistently delivering quality and success on time and within budget. CNS continues to dominate the therapeutic development process by standing as a strategic partner poised with expertise in central nervous system disorders and multiple therapeutic areas, research methodologies, regulatory requisites and evolving patient needs. CNS is dedicated to open and effective communication at all organizational levels, and to supporting sponsor confidence through simplified contracting, timely enrollment, proactive trial execution, and quality data delivery. CNS delivers accelerated product development that is coupled with integrated clinical trial management services and high quality investigative site research services for all phases within three separate divisions.

Part of Centene Corp., Merit Behavioral Care Corp. is a company that provides mental health and substance abuse services to 21 million enrollees and 800 clients in 50 states. The company is based in Park Ridge, NJ.

Comprehensive Clinical Development, Inc. provides multi therapeutic clinical research services. It engages in conducting early phase studies in Phase I-IIa for large and small biopharmaceutical, biotechnology medical device and consumer companies. The company is headquartered in Phoenix, AZ.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.